MD35Z - Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland - Google Patents
Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland Download PDFInfo
- Publication number
- MD35Z MD35Z MDS20080030A MDS20080030A MD35Z MD 35 Z MD35 Z MD 35Z MD S20080030 A MDS20080030 A MD S20080030A MD S20080030 A MDS20080030 A MD S20080030A MD 35 Z MD35 Z MD 35Z
- Authority
- MD
- Moldova
- Prior art keywords
- microcalcificates
- determined
- situ
- development
- revealed
- Prior art date
Links
- 201000004933 in situ carcinoma Diseases 0.000 title abstract 5
- 238000011065 in-situ storage Methods 0.000 title abstract 5
- 210000005075 mammary gland Anatomy 0.000 title abstract 4
- 238000000034 method Methods 0.000 title 1
- 238000002591 computed tomography Methods 0.000 abstract 4
- 238000002604 ultrasonography Methods 0.000 abstract 4
- 210000001165 lymph node Anatomy 0.000 abstract 3
- 206010057687 Bloody discharge Diseases 0.000 abstract 2
- 206010027476 Metastases Diseases 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 101100161887 Caenorhabditis elegans acr-5 gene Proteins 0.000 abstract 1
- 101100322245 Caenorhabditis elegans des-2 gene Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010053459 Secretion discharge Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000762 glandular Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 201000003159 intraductal papilloma Diseases 0.000 abstract 1
- 238000011835 investigation Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000001173 tumoral effect Effects 0.000 abstract 1
Landscapes
- Ultra Sonic Daignosis Equipment (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
The invention refers to medicine, particularly oncology and can be used for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland for determining the treatment.Summary of the invention includes carrying out of clinical, ultrasound and mammographic investigations, carrying out of computer tomography. If clininally are not revealed objective or subjective signs or it is determined presence of serous discharge from the mammary gland duct, at the ultrasound examination are revealed diffuse changes in the glandular tissue, at the mammographic examination are determined up to 5 microcalcificates to 1 cm2, according to Le Gal I-st or II-nd type, according to the Classification of the American College of Radiology (ACR) 1, 2 or 3 and at the computer tomography without pathology and absence of suspicious regional lymph nodes for presence of metastases, it is appreciated a minor risk of development of the noninvasive carcinoma in situ. If clinically there are present inflammation signs or induration with serous or serous-bloody discharge from the mammary gland duct, at the ultrasound examination it is revealed the localized fibroadenomatosis, suspicion of microcalcificates presence, at the mammographic examination there are determined up to 10 microcalcificates to 1 cm2, according to Le Gal III-rd type, according to ACR 4 and at the computer tomography is determined induration, up to 10 microcalcificates to 1 cm2, intraductal papilloma and absence of suspicious regional lymph nodes for presence of matastases, it is appreciated a medium risk of development of the noninvasive carcinoma in situ, and if clinically is determined induration or tumoral formation with bloody discharge, at the ultrasound examination it is revealed the localized fibroadenomatosis or a formation with microcalcificates, at the mammographic examination there are revealed more than 10 microcalcificates to 1 cm2, according to Le Gal IV -V type, according to ACR 5 and at the computer tomography is determined tumor with reduced density or localized fibroadenomatosis, multiple intraductal papillomae, more than 10 microcalcificates to 1 cm2 and absence of suspicious regional lymph nodes for presence of metastases, it is appreciated a major risk of development of the noninvasive carcinoma in situ.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20080030A MD35Z (en) | 2008-12-02 | 2008-12-02 | Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20080030A MD35Z (en) | 2008-12-02 | 2008-12-02 | Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD35Y MD35Y (en) | 2009-06-30 |
| MD35Z true MD35Z (en) | 2010-01-31 |
Family
ID=40942312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20080030A MD35Z (en) | 2008-12-02 | 2008-12-02 | Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD35Z (en) |
Citations (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD106C2 (en) * | 1993-11-12 | 1995-06-30 | Онкологический Институт Республики Молдова | Method of treatment for mamma cancer |
| MD446G2 (en) * | 1995-07-07 | 1996-11-30 | Онкологический Институт Республики Молдова | Method for mamma cancer treatment |
| MD798G2 (en) * | 1996-11-15 | 1998-05-31 | Онкологический Институт Республики Молдова | Method of the mamma cancer treatment |
| MD962G2 (en) * | 1997-07-24 | 1998-12-31 | Онкологический Институт Республики Молдова | Method for radical mastectomy |
| MD1569G2 (en) * | 1999-12-17 | 2001-06-30 | Онкологический Институт Республики Молдова | Method of treatment of breast canceeeer in the preoperation period |
| MD1630G2 (en) * | 1999-06-04 | 2001-09-30 | Онкологический Институт Республики Молдова | Method of radical mastectomy in breast cancer |
| EA002054B1 (en) * | 1996-10-30 | 2001-12-24 | Эли Лилли Энд Компани | Method for preventing breast cancer |
| EA002933B1 (en) * | 1997-11-28 | 2002-10-31 | Масаюки Мацуура | Method of wave therapy and apparatus therefor |
| EA003256B1 (en) * | 1997-08-29 | 2003-02-27 | Байоджен, Инк. | METHOD FOR TREATING MALIGNANT TUMOR BY IN VIVO GENE THERAPY WITH USE OF GENES ENCODING INTERFERON-beta |
| EA200200943A1 (en) * | 2000-03-03 | 2003-02-27 | Фармация Италия С.П.А. | HORMONAL THERAPY OF BREAST CANCER |
| EA004634B1 (en) * | 1996-07-18 | 2004-06-24 | Корнелл Рисерч Фаундейшн, Инк | Treatment and diagnosis of cancer |
| EA005601B1 (en) * | 1999-10-06 | 2005-04-28 | Байоджен, Инк. | Method of treating a mammal having malignant tumors characterized by abnormally high expression of a proliferation inducing ligand (april) in cells |
| EA006097B1 (en) * | 1999-04-09 | 2005-08-25 | Авентис Фарма С.А. | Treating of cancers of docetaxel in combination with recombinant humanized monoclonal anti-her2 antibody |
| EA006295B1 (en) * | 2000-10-02 | 2005-10-27 | Фармация Италия С.П.А. | Use of distamycin derivatives for antitumor therapy |
| EA006684B1 (en) * | 2000-06-23 | 2006-02-24 | Фармация Италия С.П.А. | Combined therapy against tumors comprising using substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors |
| EA006709B1 (en) * | 2000-06-23 | 2006-02-24 | Фармация Италия С.П.А. | Combined therapy against tumors comprising use of substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| MD2849G2 (en) * | 2005-05-16 | 2006-04-30 | Василе ЖОВМИР | Method of mammary cancer treatment to patients of old age |
| EA008502B1 (en) * | 2000-06-23 | 2007-06-29 | НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. | Combined therapy against tumors comprising submitted acryloyl distamycin derivatives and alkylating agents |
| MD3248G2 (en) * | 2006-06-30 | 2007-09-30 | Василе ЖОВМИР | Method of mammary cancer treatment |
| MD3772G2 (en) * | 2008-05-12 | 2009-07-31 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Method for treating mammary cancer with metastases |
| MD3671G2 (en) * | 2007-11-02 | 2009-09-30 | Онкологический Институт Республики Молдова | Method of subtotal mastectomy in the mammary upper dial cancer |
-
2008
- 2008-12-02 MD MDS20080030A patent/MD35Z/en not_active IP Right Cessation
Patent Citations (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD106C2 (en) * | 1993-11-12 | 1995-06-30 | Онкологический Институт Республики Молдова | Method of treatment for mamma cancer |
| MD446G2 (en) * | 1995-07-07 | 1996-11-30 | Онкологический Институт Республики Молдова | Method for mamma cancer treatment |
| EA004634B1 (en) * | 1996-07-18 | 2004-06-24 | Корнелл Рисерч Фаундейшн, Инк | Treatment and diagnosis of cancer |
| EA002054B1 (en) * | 1996-10-30 | 2001-12-24 | Эли Лилли Энд Компани | Method for preventing breast cancer |
| MD798G2 (en) * | 1996-11-15 | 1998-05-31 | Онкологический Институт Республики Молдова | Method of the mamma cancer treatment |
| MD962G2 (en) * | 1997-07-24 | 1998-12-31 | Онкологический Институт Республики Молдова | Method for radical mastectomy |
| EA003256B1 (en) * | 1997-08-29 | 2003-02-27 | Байоджен, Инк. | METHOD FOR TREATING MALIGNANT TUMOR BY IN VIVO GENE THERAPY WITH USE OF GENES ENCODING INTERFERON-beta |
| EA002933B1 (en) * | 1997-11-28 | 2002-10-31 | Масаюки Мацуура | Method of wave therapy and apparatus therefor |
| EA006097B1 (en) * | 1999-04-09 | 2005-08-25 | Авентис Фарма С.А. | Treating of cancers of docetaxel in combination with recombinant humanized monoclonal anti-her2 antibody |
| MD1630G2 (en) * | 1999-06-04 | 2001-09-30 | Онкологический Институт Республики Молдова | Method of radical mastectomy in breast cancer |
| EA005601B1 (en) * | 1999-10-06 | 2005-04-28 | Байоджен, Инк. | Method of treating a mammal having malignant tumors characterized by abnormally high expression of a proliferation inducing ligand (april) in cells |
| MD1569G2 (en) * | 1999-12-17 | 2001-06-30 | Онкологический Институт Республики Молдова | Method of treatment of breast canceeeer in the preoperation period |
| EA200200943A1 (en) * | 2000-03-03 | 2003-02-27 | Фармация Италия С.П.А. | HORMONAL THERAPY OF BREAST CANCER |
| EA005413B1 (en) * | 2000-03-03 | 2005-02-24 | Фармация Италия С.П.А. | Breast cancer hormonal therapy |
| EA006684B1 (en) * | 2000-06-23 | 2006-02-24 | Фармация Италия С.П.А. | Combined therapy against tumors comprising using substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors |
| EA006709B1 (en) * | 2000-06-23 | 2006-02-24 | Фармация Италия С.П.А. | Combined therapy against tumors comprising use of substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| EA008502B1 (en) * | 2000-06-23 | 2007-06-29 | НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. | Combined therapy against tumors comprising submitted acryloyl distamycin derivatives and alkylating agents |
| EA006295B1 (en) * | 2000-10-02 | 2005-10-27 | Фармация Италия С.П.А. | Use of distamycin derivatives for antitumor therapy |
| MD2849G2 (en) * | 2005-05-16 | 2006-04-30 | Василе ЖОВМИР | Method of mammary cancer treatment to patients of old age |
| MD3248G2 (en) * | 2006-06-30 | 2007-09-30 | Василе ЖОВМИР | Method of mammary cancer treatment |
| MD3671G2 (en) * | 2007-11-02 | 2009-09-30 | Онкологический Институт Республики Молдова | Method of subtotal mastectomy in the mammary upper dial cancer |
| MD3772G2 (en) * | 2008-05-12 | 2009-07-31 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Method for treating mammary cancer with metastases |
Non-Patent Citations (2)
| Title |
|---|
| Liberman L. Cancer Screening with MRI-What Are the Data for Patients at High Risk? New Engl. J. Med., 2005, 35 (5), p. 497-500 * |
| Sakofaras G.H., Farley D.R. Optimal management of ductal carcinoma in situ of the breast. Surgical Oncology, №12, 2003 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD35Y (en) | 2009-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Farasat et al. | A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics | |
| Reimer et al. | Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial | |
| Girardi et al. | Breast ultrasound in 22,131 asymptomatic women with negative mammography | |
| Sue et al. | Predictors of microinvasion and its prognostic role in ductal carcinoma in situ | |
| Kunisaki et al. | Clinicopathologic Characteristics and Surgical Outcomes of Mucinous Gastric Carcinoma: C. KUNISAKI ET AL. | |
| Singletary et al. | Defining the clinical diagnosis of inflammatory breast cancer | |
| Zhu et al. | Differentiation of gastric true leiomyoma from gastric stromal tumor based on biphasic contrast-enhanced computed tomographic findings | |
| Ampil et al. | Carcinoma of the axillary tail of Spence: a case series | |
| Veeratterapillay et al. | Adenoid cystic carcinoma of the breast: case report and review of literature | |
| Khajotia et al. | Unusually large breast tumour in a middle-aged woman | |
| MD35Z (en) | Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland | |
| Dawood et al. | Clinical aspect of inflammatory breast cancer: Diagnosis, criteria, controversy | |
| Liu et al. | The prognostic value of circumferential resection margin in esophageal squamous cell carcinoma after concurrent chemoradiation therapy and surgery | |
| Xu et al. | Mammography-detected ultrasound-negative asymptomatic micro-calcifications in Chinese women: would it be safe to watch and wait? | |
| Ajkay et al. | Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities | |
| Greif et al. | Carcinoma within solitary ductal papilloma of the breast | |
| MD24Z (en) | Method of differential treatment of noninvasive mammary carcinoma | |
| Kumar et al. | Primary malignant melanoma of the gall bladder masquerading as xanthogranulomatous cholecystitis | |
| Pradier et al. | Differences in breast carcinoma in situ between menopausal and premenopausal women | |
| Balliauw et al. | Metastatic renal cell carcinoma presenting as a breast mass in a woman with history of primary breast cancer | |
| Bahat et al. | Melanoma metastasis to the breast: a diagnostic pitfall | |
| Fadhel et al. | Beyond Boundaries: Metastasis of Cervical Squamous Cell Carcinoma to the Kidney | |
| Koelmeyer et al. | Abstract P6-12-16: L-Dex surveillance of breast cancer-related lymphoedema: A retrospective study | |
| Rosbottom et al. | Metastasis of recurrent colonic adenocarcinoma to the mouth | |
| Fernandes et al. | Intraductal papillary mucinous neoplasm presenting with recurrent pancreatitis: a report of a painful 3-decade-long history |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) | ||
| MM4Y | Short-term patent definitely lapsed due to non-payment of fees |